Most cases of myocarditis have been reported among Israelis under the age of 30, the Ministry of Health said.
In Israel, dozens of cases of heart inflammation have been detected among more than 5 million people vaccinated against coronavirus, mainly after the second dose of the drug from Pfizer. This is reported by Reuters with reference to the Israeli Ministry of Health on Monday, April 26.
- Does This Mean We Stopped Being Animal and Started Being Human Due to ‘Copy Paste’ Errors?
- The One Lifestyle Choice That Could Reduce Your Heart Disease Risk By More Than 22%
- Aging: This Is What Happens Inside Your Body Right After Exercise
- Immune-Boosting Drink that Mimics Fasting to Reduce Fat – Scientists ‘Were Surprised’ By New Findings
- Gun Violence in America: What They Don’t Talk About at the Debate
“The Health Ministry is currently examining whether there is an excess in morbidity (disease rate) and whether it can be attributed to the vaccines,” said Nachman Ash, Israel’s pandemic program coordinator, adding that no conclusions have been drawn so far.
According to him, most cases of myocarditis are registered among people under the age of 30. However, it will be difficult to determine the link between heart disease and vaccination, because myocarditis can be caused by various viruses. A similar number of cases of heart inflammation have been reported in previous years, Nachman Ash added.
Pfizer said it is in regular contact with the Israeli Ministry of Health to verify the data on its vaccine. In particular, the company said it was “aware of Israeli observations of myocarditis, which occurred primarily among young people who received the Pfizer-BioNTech COVID-19 vaccine.”
“Adverse events are regularly and thoroughly reviewed and we have not observed a higher rate of myocarditis than what would be expected in the general population. A causal link to the vaccine has not been established”
the company said.
“There is no evidence at this time to conclude that myocarditis is a risk associated with the use of Pfizer/BNT COVID-19 vaccine.”
“It’s a situation that should be looked into, and we need to wait for a final report, but in an interim analysis it seems the risk of getting sick from COVID-19 is much higher than from the vaccine’s adverse events, and the risk of peri/myo-carditis following the vaccine is low and temporary”
said Nadav Davidovitch, director of the school of public health at Israel’s Ben Gurion University.
As you know, Israel is one of the world leaders in vaccination against coronavirus. More than 5.3 million people received the first dose of the vaccine, and 5 million people received the second dose.
Fully vaccinated about 54% of the country’s population and about 74% of the adult population (over 16 years old).